PROM1 and cancer: Furthermore, the logistic regression (p = 0.006, R2 = 0.15) showed that for every 1% or more cells in the nucleus expressing CD133, there was a 2% higher chance that the cancer stage will be at least IB, and not IA according to FIGO (OR = 1.02; 95% Cl = 1.006–1.04, p = 0.009).